Advertisement
U.S. Markets open in 3 hrs 52 mins

NLS Pharmaceutics AG (NLSPW)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Visitors trend2W10W9M
0.0114+0.0013 (+12.87%)
At close: 04:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close0.0101
Open0.0115
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0100 - 0.0115
52 Week Range0.0050 - 0.1700
Volume2,723
Avg. Volume11,593
Market CapN/A
Beta (5Y Monthly)-0.58
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Pharmaceutical Technology

    NLS and Kadimastem stocks soar following merger agreement

    The stocks for both Swiss and Israeli biotechs were up over 20% after the companies signed a merger agreement.

  • TipRanks

    NLS Pharmaceutics, Kadimastem enter definitive merger agreement

    NLS Pharmaceutics (NLSP) and Kadimastem announced that they have entered into a definitive merger agreement to combine the two companies to focus on advancing NLS’ promising, first-in class Dual Orexin Agonist platform and Kadimastem’s allogenic cell therapy program with its clinical assets. Following the closing of the transactions contemplated by the Merger Agreement, NLS intends to divest its other legacy assets, and the net proceeds of any such disposition, after deducting certain costs, fee